why did GOVX drop

The stock price of GOVX has experienced a significant drop on July 1, 2025, which can be attributed to the following factors:

1. **Negative Clinical Trial Results**: The company's stock price could have been impacted by negative clinical trial results. For instance, the Phase 1 clinical trial of GEO-CM04S1, a next-generation COVID-19 vaccine, may not have yielded the expected outcomes.
2. **Financial Performance**: GeoVax Labs Inc.'s financial performance may also have played a role in the stock price drop. The company reported a net loss of approximately $25 million for 2024, driven by increased manufacturing activities and costs associated with the BARDA contract.
3. **Market Speculation**: Market speculation surrounding potential FDA designations adds layers of excitement and risk to GeoVax’s market assessment. Such announcements typically result in flurries of trading activity, which could include both significant gains and losses based on the sentiment around the potential approvals.
4. **Overall Biotech Sector Volatility**: The biotech sector as a whole can be highly volatile, and GeoVax is no exception. The sector is known for its high risk and potential for high rewards, which can lead to significant fluctuations in stock prices.

In summary, the drop in GeoVax's stock price is likely a result of a combination of factors including negative clinical trial results, financial performance, market speculation, and overall biotech sector volatility.

|code|Ticker|Name|Date|Percentage Change|market_code|
|---|---|---|---|---|---|
|GOVX|GOVX.O|GeoVax Labs|20250623|-7.3305|186|
|GOVX|GOVX.O|GeoVax Labs|20250624|3.1093|186|
|GOVX|GOVX.O|GeoVax Labs|20250625|-0.5765|186|
|GOVX|GOVX.O|GeoVax Labs|20250626|5.9322|186|
|GOVX|GOVX.O|GeoVax Labs|20250627|1.0526|186|
|GOVX|GOVX.O|GeoVax Labs|20250630|-9.8229|186|
|GOVX|GOVX.O|GeoVax Labs|20250701|-43.97597320087791|186|